Tarsus Pharmaceuticals News

Tarsus Pharmaceuticals Analyst Ratings

BenzingaFeb 28 07:47 ET

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Tarsus Pharmaceuticals (TARS) and Springworks Therapeutics (SWTX)

TipRanksFeb 28 05:50 ET

Goldman Sachs Initiates Coverage On Tarsus Pharmaceuticals With Neutral Rating, Announces Price Target of $19

BenzingaNov 20, 2023 04:43 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 20, 2023 04:41 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Knight Therapeutics (OtherKHTRF), Tarsus Pharmaceuticals (TARS) and Illumina (ILMN)

TipRanksNov 10, 2023 10:20 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaNov 10, 2023 07:43 ET

Analysts Conflicted on These Healthcare Names: Nurix Therapeutics (NRIX), Tarsus Pharmaceuticals (TARS) and TG Therapeutics (TGTX)

TipRanksOct 16, 2023 06:31 ET

Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $49

BenzingaSep 11, 2023 09:52 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaSep 11, 2023 09:51 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaAug 14, 2023 08:37 ET

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Lowers Price Target to $42

BenzingaAug 11, 2023 06:26 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaAug 11, 2023 06:25 ET

HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $44, Maintains Buy Rating

MT NewswiresJul 26, 2023 09:48 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tarsus Pharmaceuticals (TARS), Kiniksa Pharmaceuticals (KNSA) and Danaher (DHR)

TipRanksJul 26, 2023 06:41 ET

HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $50

BenzingaJul 26, 2023 06:10 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaJul 26, 2023 06:09 ET

Analysts Conflicted on These Healthcare Names: Gossamer Bio (GOSS), Karyopharm Therapeutics (KPTI) and Tarsus Pharmaceuticals (TARS)

TipRanksJul 26, 2023 03:40 ET

Tarsus Pharmaceuticals Analyst Ratings

BenzingaJul 18, 2023 09:35 ET

Analysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ), Tarsus Pharmaceuticals (TARS) and Roivant Sciences (ROIV)

TipRanksJun 29, 2023 06:20 ET

HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $44 From $40, Keeps Buy Rating

MT NewswiresJun 26, 2023 07:50 ET